2022 · Poster Presentation · Poster Presentation · Gastroenterology
12
Total Publications
2
Oral Presentation
10
Poster Presentation
2021 · Poster Presentation · Poster Presentation · Gastroenterology
Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Biologic-naïve Patients with Crohn’s Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort.
Read more →2020 · Oral Presentation · Oral Presentation · Gastroenterology
Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD.
Read more →2020 · Oral Presentation · Approval / Commercialization · Hepatology
Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH.
Read more →2019 · Poster Presentation · Care · Hepatology
Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid (OCA) in TARGET-PBC, a diverse, large United States (US) real- world cohort.
Read more →2019 · Poster Presentation · Approval / Commercialization · Hepatology
Change in Lipids: Characteristics and Response to Obeticholic Acid (OCA) in TARGET-PBC, a Diverse, Large United States (US) Real-world Cohort.
Read more →2018 · Poster Presentation · Poster Presentation · Hepatology
Nonalcoholic Fatty Liver Disease in Children in the U.S.: Clinical Characteristics of Participants Enrolled in TARGET-NASH.
Read more →2018 · Poster Presentation · Approval / Commercialization · Hepatology
Real World Evidence Showing High Rates of Cardiovascular Events in NAFLD Patients Regardless of Liver Disease.
Read more →2018 · Poster Presentation · Approval / Commercialization · Hepatology
Primary Biliary Cholangitis (PBC) in the U.S.: Real World Effectiveness of Obeticholic Acid in TARGET-PBC.
Read more →2018 · Poster Presentation · Care · Hepatology
Primary Biliary Cholangitis (PBC) in the U.S.: Clinical Characteristics of Patients Enrolled in TARGET-PBC.
Read more →2017 · Poster Presentation · Poster Presentation · Hepatology